Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1[Eculizumab]1件: Eculizumab (Eculizumab)1件: Eculizumab (Eculizumab, Eculizumab-aagh, Eculizumab-aeeb) 💬 1件: C5 💬 11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬1件: 62 💬
2ABP 959 - biosimilar to eculizumab1件: Eculizumab (Eculizumab)1件: Eculizumab (Eculizumab, Eculizumab-aagh, Eculizumab-aeeb) 💬 1件: C5 💬 11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬1件: 62 💬
3ABP 959 - proposed biosimilar to eculizumab1件: Eculizumab (Eculizumab)1件: Eculizumab (Eculizumab, Eculizumab-aagh, Eculizumab-aeeb) 💬 1件: C5 💬 11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬1件: 62 💬
4ECULIZUMAB1件: Eculizumab (Eculizumab)1件: Eculizumab (Eculizumab, Eculizumab-aagh, Eculizumab-aeeb) 💬 1件: C5 💬 11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬8件: 11, 13, 14, 61, 62, 109, 221, 223 💬
5Eculizumab (Soliris®)1件: Eculizumab (Eculizumab)1件: Eculizumab (Eculizumab, Eculizumab-aagh, Eculizumab-aeeb) 💬 1件: C5 💬 11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬1件: 13 💬
6Eculizumab administration1件: Eculizumab (Eculizumab)1件: Eculizumab (Eculizumab, Eculizumab-aagh, Eculizumab-aeeb) 💬 1件: C5 💬 11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬1件: 13 💬
7Eculizumab Injection1件: Eculizumab (Eculizumab)1件: Eculizumab (Eculizumab, Eculizumab-aagh, Eculizumab-aeeb) 💬 1件: C5 💬 11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬1件: 62 💬
8Eculizumab+IVMP1件: Eculizumab (Eculizumab)1件: Eculizumab (Eculizumab, Eculizumab-aagh, Eculizumab-aeeb) 💬 1件: C5 💬 11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬1件: 13 💬
9Other: Eculizumab1件: Eculizumab (Eculizumab)1件: Eculizumab (Eculizumab, Eculizumab-aagh, Eculizumab-aeeb) 💬 1件: C5 💬 11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬1件: 109 💬
10SB12 (proposed eculizumab biosimilar)1件: Eculizumab (Eculizumab)1件: Eculizumab (Eculizumab, Eculizumab-aagh, Eculizumab-aeeb) 💬 1件: C5 💬 11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬1件: 62 💬
11Soliris (eculizumab)1件: Eculizumab (Eculizumab)1件: Eculizumab (Eculizumab, Eculizumab-aagh, Eculizumab-aeeb) 💬 1件: C5 💬 11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬1件: 62 💬
12Soliris ™ (eculizumab)1件: Eculizumab (Eculizumab)1件: Eculizumab (Eculizumab, Eculizumab-aagh, Eculizumab-aeeb) 💬 1件: C5 💬 11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬1件: 62 💬